Copyright
©The Author(s) 2021.
World J Clin Oncol. Aug 24, 2021; 12(8): 623-645
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.623
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.623
Table 2 2007 Milan neuroendocrine tumor criteria[143]
Inclusion criteria |
Histology G1/G2 neuroendocrine tumor with or without syndrome |
Primary tumor drained by the portal system (pancreas and intermediate gut: from distal stomach to sigmoid colon) |
Primary tumor removed with a curative resection (pretransplant removal of all extrahepatic tumor deposits) through surgical procedures separate from transplantation |
Less than 50% tumor load in the liver parenchyma |
Response to treatment or stable disease for at least 6 mo pretransplantation |
Age younger than 55 yr (relative criteria) |
Exclusion criteria |
High-grade neuroendocrine carcinomas |
General contraindications for liver transplantation, including previous tumors |
Non-gastrointestinal NET or tumors not drained by the portal system |
- Citation: Lang SA, Bednarsch J, Czigany Z, Joechle K, Kroh A, Amygdalos I, Strnad P, Bruns T, Heise D, Ulmer F, Neumann UP. Liver transplantation in malignant disease. World J Clin Oncol 2021; 12(8): 623-645
- URL: https://www.wjgnet.com/2218-4333/full/v12/i8/623.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i8.623